Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSD’s software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The Company has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.


OTCPK:MEDVF - Post by User

Post by woolcoon Mar 08, 2021 7:55pm
162 Views
Post# 32749140

So Crazy....our valuation at around 40M

So Crazy....our valuation at around 40MAnd companies going public...is the Canadian POND...vs the USA OCEAN.....losing tons of cash....and lower revenue...in same space with multiples in valuation hire than Medi.

We need to "re-go" public....say to the TSX or something as the valuation of this company is a complete joke compared to peers...

Dialogue, which offers medical services over the internet, confirmed a Globe and Mail report from last month

that the offering would be led by National Bank of Canada 
NA-T +2.35%increase
 
, Royal Bank of Canada 
RY-T +1.71%increase
 
, Bank of Nova Scotia 
BNS-T +0.79%increase
 
and Toronto-Dominion Bank 
TD-T +1.61%increase
 
. The rest of the underwriting syndicate includes CIBC World Markets, Desjardins Securities, Canaccord Genuity 
CF-T -2.18%decrease
 
, iA Private Wealth, INFOR Financial and Laurentian Bank Securities. Dialogue will trade under the ticker symbol CARE.

 

The five-year-old company has raised more than $100-million in venture capital to date from Sun Life Financial Inc. 

SLF-T +1.63%increase
 
, National Bank of Canada, Power Corp. of Canada’s Portag3 Ventures, the Caisse de dpt et placement du Qubec, White Star Capital, HV Holtzbrinck Ventures and others.

 

Dialogue’s preliminary prospectus reveals it has experienced explosive growth, owing largely to the pandemic. Revenues from the company’s online health service in 2020 nearly tripled to $29-million from $10.1-million in 2019. That was up from was $4-million in 2018. The service is now available to 2.5 million Canadians and their dependants, offered through four of Canada’s five largest group insurers. Dialogue lost $20.5-million in 2020, compared with a $12-million loss in 2019.

Total revenue reached $35.8-million in 2020 after Dialogue last year purchased Argumed Consulting Group GmbH, a German provider of occupational health and safety services, and Optima Global Health Inc., a Canadian employee assistance program seller. Annual recurring revenues were at a rate of $60-million early this year.

 

Becoming a publicly-traded company ”will not change our No. 1 focus: facilitating the delivery of high-quality care to our members,” chief executive officer and co-founder Cherif Habib said in the company’s prospectus.

Valuations for public tech companies have skyrocketed since the start of the pandemic as people sheltering at home increasingly turned to online tools for shopping, workplace communications, training – and medical consultations.

The Globe and Mail first reported last summer that Dialogue was considering going public. Since then several Canadian tech companies have hired bankers or filed to go public. Many initially met with a warm investor response in what has shaped up to be the busiest period for IPOs since the dot-com boom. That includes the two largest tech IPOs in Canadian history, by Nuvei Corp. 

NVEI-T -4.45%decrease
 
in September and Telus International (Cda) Inc. 
TIXT-T +0.69%increase
 
last month. MindBeacon Holdings Inc. 
MBCN-T -0.51%decrease
 
, a smaller and earlier-stage company than Dialogue offering online mental-health services, raised $65-million in a highly oversubscribed IPO in December. Industry observers believe Toronto telemedicine startup Maple Corp. could also be a near-term IPO candidate.

 

But Dialogue’s proposed IPO is also coming into a tough market. Tech stocks have sustained sharp losses in recent days, including Shopify Inc. 

SHOP-T -4.56%decrease
 
, which lost its standing as Canada’s most valuable company Monday to Royal Bank of Canada.

 

 
<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse